Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland.
Epidemiological studies have consistently shown that an early full-term pregnancy is protective against breast cancer. We hypothesize that the hormonal milieu that is present during pregnancy results in persistent changes in the pattern of gene expression in the mammary gland, leading to permanent changes in cell fate that determine the subsequent proliferative response of the gland. To investigate this hypothesis, we have used suppression subtractive hybridization to identify genes that are persistently up-regulated in the glands of E- and progesterone (P)-treated Wistar-Furth rats 28 d after steroid hormone treatment compared with age-matched virgins. Using this approach, a number of genes displaying persistent altered expression in response to previous treatment with E and P were identified. Two markers have been characterized in greater detail: RbAp46 and a novel gene that specifies a noncoding RNA (designated G.B7). Both were persistently up-regulated in the lobules of the regressed gland and required previous treatment with both E and P for maximal persistent expression. RbAp46 has been implicated in a number of complexes involving chromatin remodeling, suggesting a mechanism whereby epigenetic factors responsible for persistent changes in gene expression may be related to the determination of cell fate. These results provide the first support at the molecular level for the hypothesis that hormone-induced persistent changes in gene expression are present in the involuted mammary gland.
Ginger
M R
MR
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030-3411, USA.
Gonzalez-Rimbau
M F
MF
Gay
J P
JP
Rosen
J M
JM
D000818:Animals; D015152:Blotting, Northern; D002352:Carrier Proteins / Q000187:drug effects / Q000235:genetics; D003001:Cloning, Molecular; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D017403:In Situ Hybridization / Q000379:methods; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000502:physiology*; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000187:drug effects / Q000235:genetics; D010546:Perphenazine / Q000494:pharmacology; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood; D022661:RNA, Untranslated / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D015854:Up-Regulation
D002352:Carrier Proteins; D009687:Nuclear Proteins; D022661:RNA, Untranslated; D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D010546:Perphenazine